[{"id": "1f09b94e1946abae23434c331d898d9e", "cik": "1628171", "ticker": "RVMD", "name": "Margaret Horn, J.D.", "position": "Chief Operating Officer and General Counsel", "year": 2021, "salary": 482333, "bonus": 0, "stockAwards": 636750, "optionAwards": 1486522, "nonEquityIncentiveCompensation": 283700, "otherCompensation": 7000, "total": 2896305}, {"id": "7c103ccb6a019e92779a2c2d7043fbd5", "cik": "1628171", "ticker": "RVMD", "name": "Jack Anders", "position": "Senior Vice President, Finance, and Principal Accounting Officer", "year": 2021, "salary": 311333, "bonus": 0, "stockAwards": 314130, "optionAwards": 733351, "nonEquityIncentiveCompensation": 143800, "otherCompensation": 7000, "total": 1509614}, {"id": "e99b69172d453c6be1974215e744b26d", "cik": "1628171", "ticker": "RVMD", "name": "Steve Kelsey, M.D.", "position": "President, Research and Development", "year": 2021, "salary": 482333, "bonus": 0, "stockAwards": 636750, "optionAwards": 1486522, "nonEquityIncentiveCompensation": 283700, "otherCompensation": 7000, "total": 2896305}, {"id": "dff4d3b4281f2e14498908bf68c452fb", "cik": "1628171", "ticker": "RVMD", "name": "Xiaolin Wang Sc.D.", "position": "Executive Vice President and Clinical Development", "year": 2021, "salary": 377833, "bonus": 0, "stockAwards": 475440, "optionAwards": 1109936, "nonEquityIncentiveCompensation": 197600, "otherCompensation": 7000, "total": 2167809}, {"id": "f89d659dda2c04ffa76b433347ddb37f", "cik": "1628171", "ticker": "RVMD", "name": "Mark A. Goldsmith, M.D., Ph.D.", "position": "President and Chief Executive Officer", "year": 2021, "salary": 580833, "bonus": 0, "stockAwards": 2037600, "optionAwards": 4785184, "nonEquityIncentiveCompensation": 418300, "otherCompensation": 7000, "total": 7828917}, {"id": "1164b33da204d6925573495692b0fbc0", "cik": "1628171", "ticker": "RVMD", "name": "Mark A. Goldsmith, M.D., Ph.D.", "position": "President and Chief ExecutiveOfficer", "year": 2020, "salary": 554011, "bonus": 0, "stockAwards": 0, "optionAwards": 1426200, "nonEquityIncentiveCompensation": 406000, "otherCompensation": 2000, "total": 2388211}, {"id": "6c96d181510abd35fe481ab62f5923b6", "cik": "1628171", "ticker": "RVMD", "name": "Margaret Horn, J.D.", "position": "Chief Operating Officerand General Counsel", "year": 2020, "salary": 459691, "bonus": 0, "stockAwards": 0, "optionAwards": 522559, "nonEquityIncentiveCompensation": 273700, "otherCompensation": 2000, "total": 1257950}, {"id": "5b1810cca0a6622ba89b55501fb0b45a", "cik": "1628171", "ticker": "RVMD", "name": "Steve Kelsey, M.D.", "position": "President, Researchand Development", "year": 2020, "salary": 464210, "bonus": 0, "stockAwards": 0, "optionAwards": 522559, "nonEquityIncentiveCompensation": 273700, "otherCompensation": 2000, "total": 1262469}, {"id": "1ec8507765c9da1216cd9d68b76f00f2", "cik": "1628171", "ticker": "RVMD", "name": "Mark A. Goldsmith, M.D., Ph.D.", "position": "President and Chief ExecutiveOfficer", "year": 2019, "salary": 504300, "bonus": 0, "stockAwards": 0, "optionAwards": 3808974, "nonEquityIncentiveCompensation": 260980, "otherCompensation": 2000, "total": 4576254}, {"id": "bfbfa23e0e47602dd8e7aab8b0a9364c", "cik": "1628171", "ticker": "RVMD", "name": "Steve Kelsey, M.D.", "position": "President, Researchand Development", "year": 2019, "salary": 424350, "bonus": 0, "stockAwards": 0, "optionAwards": 1298253, "nonEquityIncentiveCompensation": 170800, "otherCompensation": 2000, "total": 1895403}, {"id": "92cd0d2391e4849f6e96e2a4d3aba329", "cik": "1628171", "ticker": "RVMD", "name": "Margaret Horn, J.D.", "position": "Chief Operating Officerand General Counsel", "year": 2019, "salary": 384375, "bonus": 0, "stockAwards": 0, "optionAwards": 1662587, "nonEquityIncentiveCompensation": 166150, "otherCompensation": 2000, "total": 2215112}]